VRNA - Volume dana dhuwit perusahaan Verona Pharma plc

Logo perusahaan publik veronapharma.com (VRNA)

Verona Pharma plc (VRNA) possesses high growth potential driven by low-cost mass production of inhalers following the completion of trials. David Zaccardi's management team is currently focusing on the execution of the commercial sales plan. However, geopolitical risks and raw material import complexities create certain barriers. The cash position helps assess the business's financial autonomy, while 0.44 records a new level mark.

Verona Pharma Corp - Sisa dhuwit perusahaan VRNA (periode 04.07.2022 - 18.10.2025)

Rincian metrik keuangan lan pasar Verona Pharma (VRNA)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:VRNA Verona Pharma plc
Produk merek veronapharma.com

Verona Pharma plc (VRNA) respiratory drug development is independent of economic cycles, ensuring a stable cash flow. The trend in cash reserves reflects the company's current financial flexibility while awaiting regulatory approval. This indicator captures daily changes in liquid assets, where sharp spikes may signal either capital inflows or asset sales. A high cash balance confirms the business's resilience to macro shocks.

Pesaing langsung

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Jyong Biotech - Dhuwit awis perusahaan|LGND: Dhuwit awis lan setara dhuwit awis perusahaan|AMRX: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Perrigo Company plc|ALVO: Volume dana dhuwit perusahaan|Liquidia (LQDA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Galapagos N.V.|Dhuwit awis perusahaan ANI Pharmaceuticals, Inc. (ANIP)|Volume dana dhuwit perusahaan MNKD|AMPH (Amphastar Corp) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan pacira.com PCRX|SPRY - Dhuwit awis perusahaan|Theravance Biopharma, Inc. - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AQST (Aquestive Therapeutics, Inc.)|SCPH: Volume dana dhuwit perusahaan|Tectonic Therapeutic Inc. - Sisa dhuwit perusahaan|TNXP (Tonix Pharma) - Volume dana dhuwit perusahaan|SXTC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan EPRX|BHST - Cadangan dhuwit perusahaan|eXoZymes - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan oramed.com ORMP|ENTX - Dana dhuwit perusahaan|Aset likuid perusahaan MindWalk Holdings HYFT|ABVC: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Cumberland Pharmaceuticals Inc.|Dana dhuwit perusahaan Quantum BioPharma Limited|FGEN: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan TELO|Rani Therapeutics Holdings, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Synergy CHC Corp. SNYR|Sisa dhuwit perusahaan RLYB|LEXX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Aptorum|Dhuwit awis perusahaan LYRA|Impact BioMedical Inc - Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan TNFA|YCBD - Cadangan dhuwit perusahaan|PainReform Ltd. - Dhuwit awis perusahaan|CYTO (Auris Medical) - Total volume dana dhuwit perusahaan|LIPO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OPTN (OptiNose)|PIRS: Volume dana dhuwit perusahaan|Procaps Group S.A. (PROC) - Volume dana dhuwit perusahaan|PTPI (Petros Pharma) - Volume dana dhuwit perusahaan|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan